Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 History of patients and origin of samples

From: Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature

Patient Gender Age (year) Tissue samples Associated diagnosis SR-FTIR Internal source
1 F 31 Normal liver FNH + +
2 F 26 Normal liver FNH + +
3 F 25 Normal liver FNH + +
4 M 59 Normal liver Metastasis (GC) + +
5 F 37 Normal liver FNH +
6 M 50 Normal liver Metastasis (CRC) +
7 F 26 Normal liver FNH +
8 F 39 Normal liver Hepatic adenoma +
9 F 54 Normal liver FNH +
10 F 30 Normal liver FNH +
11 M 61 Normal liver Metastasis (CRC) +
12 M 62 Cirrhosis/HCC Alcohol + +
13 M 60 Cirrhosis/HCC Alcohol + +
14 M 58 Cirrhosis/HCC Alcohol + +
15 M 49 Cirrhosis/HCC Alcohol +
16 M 84 Cirrhosis/HCC Alcohol +
17 M 57 Cirrhosis/HCC Alcohol +
18 M 60 Cirrhosis/HCC Alcohol +
19 M 61 Cirrhosis/HCC Alcohol +
20 M 61 Cirrhosis/HCC Alcohol +
21 M 67 Cirrhosis/HCC Alcohol +
22 M 49 Cirrhosis/HCC HCV +
23 F 80 Cirrhosis/HCC HCV +
24 F 66 Cirrhosis/HCC HCV +
25 F 77 Cirrhosis/HCC HCV +
26 F 56 Cirrhosis/HCC HCV +
27 F 59 Cirrhosis/HCC HCV +
28 M 68 Cirrhosis/HCC HCV +
29 M 61 Cirrhosis/HCC HCV +
30 M 71 Cirrhosis/HCC HCV +
31 M 65 Cirrhosis/HCC HCV +
32 F 66 Cirrhosis/HCC HCV +
33 F 58 Cirrhosis/HGDN with nodules of HCC HCV +
34 M 59 Cirrhosis/HGDN Alcohol +
35 M 48 Cirrhosis/Early HCC HCV +
36 M 55 Cirrhosis/HGDN HBV +
37 M 59 Cirrhosis/HGDN/HCC Alcohol + +
38 M 66 Cirrhosis/LGDN/HCC Alcohol +
39 M 53 Cirrhosis/HGDN/HCC HCV +
  1. FNH focal nodular hyperplasia, CRC colorectal cancer, GC gallbladder cancer, HBV hepatitis B virus, HCV hepatitis C virus, HCC progressed HCC, LGDN low grade dysplastic nodule, HGDN high grade dysplastic nodule